For the Inventor, By the Inventor

Enter assignee name

Merck Canada Inc.

USPTO Granted Patents = 40

CIPO Patents = 5

EPO Patents = 54

Forward Citations = 197

Loading Chart...

Loading Chart...

190 inventors (with patents filed for the assignee):

Alan B Northrup (11 out of 36 patents)

John Michael Ellis (9 out of 19 patents)

Michael D Altman (8 out of 56 patents)

4. Christian Beaulieu (8 out of 11 patents)

5. Jason Burch (8 out of 13 patents)

6. Andrew M Haidle (8 out of 25 patents)

7. Oscar Miguel Moradei (7 out of 32 patents)

8. Vouy Linh Truong (7 out of 11 patents)

9. Solomon D Kattar (7 out of 28 patents)

10. Michael Hale Reutershan (6 out of 20 patents)

11. Kerrie Spencer (6 out of 11 patents)

12. Michelle R Machacek (6 out of 31 patents)

13. Anthony Donofrio (6 out of 13 patents)

14. Sheldon N Crane (6 out of 9 patents)

15. Kaleen Konrad Childers (6 out of 12 patents)

Core Competencies:

HIV Protease Inhibitors

Spleen Tyrosine Kinase Inhibitors

CRTH2 Receptor Antagonists

Orexin Receptor Antagonists

Cysteine Protease Inhibitors

Renin Inhibitors

Stearoyl-CoA Delta-9 Desaturase Inhibitors

Triazolyl Derivatives

Indole Derivatives

Aminopyrimidines

Thiazole-Substituted Compounds

Spiro Compounds

40 patents: Sort by Forward Citations

1. 10072003 - Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their use (2018-09-11),

2. 9994587 - HIV protease inhibitors (2018-06-12),

3. 9834526 - HIV protease inhibitors (2017-12-05),

4. 9822107 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors (2017-11-21),

5. 9745295 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors (2017-08-29),

6. 9737545 - HIV protease inhibitors (2017-08-22),

7. 9586931 - Triazolyl derivatives as Syk inhibitors (2017-03-07),

8. 9487504 - Imidazolyl analogs as syk inhibitors (2016-11-08),

9. 9376418 - Substituted pyridine spleen tyrosine kinase (SYK) inhibitors (2016-06-28),

10. 9353066 - Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors (2016-05-31),

11. 9315475 - HIV protease inhibitors (2016-04-19),

12. 9242984 - Pyrazolyl derivatives as Syk inhibitors (2016-01-26),

13. 9187415 - Sulfonamides as HIV protease inhibitors (2015-11-17),

14. 9168248 - Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase (2015-10-27),

15. 9145391 - Bipyridylaminopyridines as Syk inhibitors (2015-09-29),

Merck Canada Inc. is a leading pharmaceutical company, dedicated to improving the health and lives of Canadians. They offer a wide range of prescription drugs, vaccines, and animal health products. With a focus on research and innovation, Merck Canada is committed to providing safe and effective healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

40 Patents

#38 in

#327 in Canada

#16,570 in the World

Merck Canada Inc.

Forward Citations = 197

190 inventors:

Alan B Northrup (11 out of 36 patents)

John Michael Ellis (9 out of 19 patents)

Michael D Altman (8 out of 56 patents)

4. Christian Beaulieu (8 out of 11 patents)

5. Jason Burch (8 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…